Genetic Technologies Ltd
GENE·Stocks·Miscellaneous Commercial Services·Australia·Nasdaq·USD | AUD
Price
$5.09
Today
+0.0%
YTD
+0.0%
About
Genetic Technologies is a healthcare firm that provides assessment and predictive testing tools to assist physicians in managing women's health, including diseases such as non-hereditary breast cancer. Founded in 1987, the firm is based in Fitzroy, Australia and operates primarily within the United States and Australia. Genetic Technologies' stock is listed on the NASDAQ CM with the ticker GENE. Add diversity to your eToro portfolio by purchasing GENE stock.
Price chart
Closing price history for GENE (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-0.55
P/S (TTM)1.51
P/B (TTM)-2.76
Market cap$3.71M
Cap tierMicro-cap
Industry avg P/E40.30
Profitability
Gross margin-67.90%
EBIT margin-199.86%
Net margin-151.05%
ROE-587.68%
ROA-166.29%
Earnings & Revenue
Revenue (TTM)$2.44M
Revenue growth (1Y)-56.8%
EPS (TTM)-$1.40
Free cash flow$-3.84M
Total debt$309,575.00
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.10
Employees58
Next earnings25 Feb '25
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.